Pliant Therapeutics (PLRX) Shares Outstanding (2019 - 2026)

Pliant Therapeutics (PLRX) has reported Shares Outstanding (Entity) for 8 consecutive years, with $61.9 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 0.87% year-over-year to $61.9 million in Q2 2026; TTM through Jun 2026 was $61.9 million, a 0.87% increase from a year earlier, with the FY2025 full-year figure at $61.4 million, up 0.97% from the prior year.
• Shares Outstanding (Entity) was $61.9 million for Q2 2026 at Pliant Therapeutics, roughly flat from $61.9 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $61.9 million in Q2 2026 and troughed at $36.2 million in Q1 2022.
• A 5-year average of $56.7 million and a median of $60.4 million in 2024 frame the typical range for Shares Outstanding (Entity).
• Across the five-year window, Shares Outstanding (Entity) soared 63.68% in 2023 and rose 0.86% in 2026, its largest moves.
• Over 5 years, Shares Outstanding (Entity) stood at $48.9 million in 2022, then climbed by 22.43% to $59.9 million in 2023, then climbed by 1.57% to $60.9 million in 2024, then climbed by 0.97% to $61.4 million in 2025, then increased by 0.77% to $61.9 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $61.9 million (Q2 2026), $61.9 million (Q1 2026), and $61.4 million (Q4 2025), per Business Quant data.